# Clinical Trial of PCV24 in Adults Aged ≥18 Years

> **NCT07543198** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sinovac Life Sciences Co., Ltd.** · enrollment: 385 (actual)

## Conditions studied

- Pneumococcal Infectious Disease

## Interventions

- **BIOLOGICAL:** Sinovac Low-dosage PCV24
- **BIOLOGICAL:** Sinovac Middle-dosage PCV24
- **BIOLOGICAL:** Sinovac High-dosage PCV24
- **BIOLOGICAL:** Pneumovax®

## Key facts

- **NCT ID:** NCT07543198
- **Lead sponsor:** Sinovac Life Sciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-18
- **Primary completion:** 2026-02-26
- **Final completion:** 2026-02-26
- **Target enrollment:** 385 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07543198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07543198, "Clinical Trial of PCV24 in Adults Aged ≥18 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07543198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*